Report cover image

ISSUE 6 of 6 - In Vitro Diagnostics Business Outlook: Focus on Hematology

Published Dec 30, 2025
Length 52 Pages
SKU # KLI20680049

Description

The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.

As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.

In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
  • Market Data and Forecasts: Detailed growth rates, market size, and market share to identify new opportunities.
  • Comprehensive Market View: Coverage of test categories and company profiles.
  • M&A Activities: Updates on mergers, acquisitions, partnerships, and collaborations.
  • Industry & Region Watch: Tailored strategies based on regional and industry-specific trends.
  • News Analysis: In-depth reporting on significant news and events, including exclusive information not readily available elsewhere.
Please Note: Single user allows for up to 3 users for this report.

Table of Contents

52 Pages
MARKET ANALYSIS: HEMATOLOGY
OVERVIEW OF HEMATOLOGY
MARKET OUTLOOK: HEMATOLOGY
Table: Global Hematology Testing Market, by Product Segment, 2025-2030 ($ million) [Decentralized (POC) Hematology, Laboratory-based Hematology]
Figure: Global Hematology Testing Market, by Product Segment, 2025-2030 ($ million) [Decentralized (POC) Hematology, Laboratory-based Hematology]
Table: Lab-Based and Decentralized Hematology Market Summary, 2025
Figure: Global Hematology Testing Market, Vendor Share, 2025 (%)
REGIONAL MARKET
Table: Hematology Analyzer/Reagent Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, Rest of World]
Figure: Hematology Analyzer/Reagent Market, by Setting and Region, 2025 ($ million) [Decentralized (POC) Hematology, Laboratory-based Hematology]
COMPANY BRIEFS
Danaher
Roche
SYSMEX
EXECUTIVE NEWS BRIEFING
DETACT DIAGNOSTICS AWARDED $1.6 MILLION
HEPTA BIO RECEIVES $6.7 MILLION IN SEED FUNDING
ARCORIS BIO ADVANCES NGS BIOMARKER TECHNOLOGY WITH CHF 6.3 MILLION FUNDING
CIRCULAR GENOMICS LANDS $15 MILLION SERIES A FINANCING
BRUKER ADDS NEW BOARD MEMBER
BILLIONTOONE ONBOARDS CHAIR OF AUDIT COMMITTEE
AMPLIFOLD RAISES €5 MILLION
FINANCIAL HIGHLIGHTS: EXACT SCIENCES
EXACT SCIENCES HIGHLIGHTS CONTINUED GROWTH ACROSS CANCER SCREENING AND ONCOLOGY TESTING IN Q3 2025
Figure: Exact Sciences Revenue Mix, by Product Segment, Q3 2024 vs Q3 2025 ($ million) [Precision Oncology, Screening]
Figure: Exact Sciences Revenue Mix, by Product Segment, by Quarter 2020–Q3 2025 ($ million) [COVID-19 Testing, Fecal Occult Screening, Precision Oncology]
Acquisition Pending – Abbott Laboratories to Acquire Exact Sciences
Figure: Abbott-Exact Sciences Transaction: Exact Sciences Impact and Business Strategy Outlook
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS, AND PARTNERSHIP DEALS
MERGERS AND ACQUISITIONS
Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals
PARTNERSHIPS AND COLLABORATIONS
INDUSTRY WATCH
INDUSTRY WATCH COVID-19/FLU UPDATE
REGION WATCH
TURKEY
Figure: Turkey IVD Market Strength and Challenges Profile
Turkey IVD Market, Estimated Value by Segment, 2025
BROAD-BASED COMPANY ANNOUNCEMENTS
SCANOGEN GRANTED FDA BREAKTHROUGH DEVICE DESIGNATION
BECKTON DICKINSON RECEIVES FDA CLEARANCE AND CE MARKING
QUIDELORTHO CAPTURES FDA CLEARANCE OR VITROS IMMUNODIAGNOSTIC
TOSOH BIOSCIENCE SNAGS FDA CLEARANCE
QIAGEN SET TO ACQUIRE PARSE BIOSCIENCES
THERMO FISHER GAINS CLEARANCE FOR THE EXENT ANALYZER AND ASSAY
PROMEGA ONCOMATE WINS FDA APPROVAL
PROGNOMIQ LAUNCHES LDT
ROCHE LANDS FDA CLEARANCE WITH CLIA WAIVER FOR NEW POC TEST
CO-DIAGNOSTICS FORMS NEW AI BUSINESS UNIT
FDA PROPOSES RECLASSIFICATION OF COMPANION DIAGNOSTIC ASSAYS
ASTRIN BIOSCIENCES PREPARES TO LAUNCH CERTITUDE BREAST

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.